Diebold Earnings Calls
| Release date | Apr 30, 2026 |
| EPS estimate | $0.610 |
| EPS actual | $0.600 |
| EPS Surprise | -1.64% |
| Revenue estimate | 846.233M |
| Revenue actual | 888.2M |
| Revenue Surprise | 4.96% |
| Release date | Feb 12, 2026 |
| EPS estimate | $1.61 |
| EPS actual | $3.02 |
| EPS Surprise | 87.58% |
| Revenue estimate | 1.114B |
| Revenue actual | 1.104B |
| Revenue Surprise | -0.85% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.660 |
| EPS actual | $1.39 |
| EPS Surprise | 110.61% |
| Revenue estimate | 1.114B |
| Revenue actual | 945.2M |
| Revenue Surprise | -15.16% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.610 |
| EPS actual | $0.600 |
| EPS Surprise | -1.64% |
| Revenue estimate | 987.1M |
| Revenue actual | 915.2M |
| Revenue Surprise | -7.28% |
Last 4 Quarters for Diebold
Below you can see how DBD performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $59.47 |
| EPS estimate | $0.610 |
| EPS actual | $0.600 |
| EPS surprise | -1.64% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $56.29 |
| Aug 01, 2025 | $53.99 |
| Aug 04, 2025 | $55.25 |
| Aug 05, 2025 | $56.22 |
| Aug 06, 2025 | $59.47 |
| Aug 07, 2025 | $60.00 |
| Aug 08, 2025 | $59.99 |
| Aug 11, 2025 | $59.69 |
| Aug 12, 2025 | $61.75 |
| 4 days before | 5.65% |
| 4 days after | 3.83% |
| On release day | 0.89% |
| Change in period | 9.70% |
| Release date | Nov 05, 2025 |
| Price on release | $63.24 |
| EPS estimate | $0.660 |
| EPS actual | $1.39 |
| EPS surprise | 110.61% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $57.50 |
| Oct 31, 2025 | $59.15 |
| Nov 03, 2025 | $58.85 |
| Nov 04, 2025 | $56.24 |
| Nov 05, 2025 | $63.24 |
| Nov 06, 2025 | $65.60 |
| Nov 07, 2025 | $64.50 |
| Nov 10, 2025 | $65.00 |
| Nov 11, 2025 | $65.25 |
| 4 days before | 9.98% |
| 4 days after | 3.18% |
| On release day | 3.73% |
| Change in period | 13.48% |
| Release date | Feb 12, 2026 |
| Price on release | $75.59 |
| EPS estimate | $1.61 |
| EPS actual | $3.02 |
| EPS surprise | 87.58% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $71.81 |
| Feb 09, 2026 | $70.97 |
| Feb 10, 2026 | $72.06 |
| Feb 11, 2026 | $72.36 |
| Feb 12, 2026 | $75.59 |
| Feb 13, 2026 | $80.30 |
| Feb 17, 2026 | $82.58 |
| Feb 18, 2026 | $80.69 |
| Feb 19, 2026 | $81.08 |
| 4 days before | 5.26% |
| 4 days after | 7.26% |
| On release day | 6.23% |
| Change in period | 12.91% |
| Release date | Apr 30, 2026 |
| Price on release | $76.81 |
| EPS estimate | $0.610 |
| EPS actual | $0.600 |
| EPS surprise | -1.64% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $85.64 |
| Apr 27, 2026 | $82.33 |
| Apr 28, 2026 | $82.30 |
| Apr 29, 2026 | $82.96 |
| Apr 30, 2026 | $76.81 |
| May 01, 2026 | $77.86 |
| May 04, 2026 | $76.62 |
| May 05, 2026 | $77.53 |
| May 06, 2026 | $79.53 |
| 4 days before | -10.31% |
| 4 days after | 3.54% |
| On release day | 1.37% |
| Change in period | -7.13% |
Diebold Earnings Call Transcript Summary of Q1 2026
Diebold Nixdorf reported a strong Q1 2026 with revenue of $888M (up 6% YoY) and adjusted EBITDA of $99M (up 14% YoY). Backlog rose sequentially to ~$790M. Key growth drivers: banking (continued strength in ATMs and expanding branch automation including teller cash recyclers and transaction processing platforms) and retail (revenues +25% YoY, North America up ~70% off a small base, multiple large EPOS and self-checkout wins). Product gross margins improved (product margin 26.3% overall; banking product margins notably higher), while service margins are temporarily pressured due to planned investments in people and field technology but are expected to improve sequentially. Free cash flow was $21M in Q1 (sixth consecutive positive quarter); company targets full-year FCF of $255M–$270M and expects positive FCF each quarter in 2026. Balance sheet remains strong with ~ $680M liquidity, net debt leverage ~1.2x, and $200M repurchase authorization (Q1 repurchases ~$55M). 2026 guidance: revenue $3.86B–$3.94B, adjusted EBITDA $510M–$535M, adjusted EPS $5.25–$5.75, and continued focus on cost reductions and Lean initiatives to drive margin expansion and operating expense improvement. Management emphasized execution, growing pipeline (especially in North America retail), service efficiency gains from field technician software, and disciplined capital returns. Risks noted: component cost inflation (memory) and macro dynamics, but management says they are mitigating via pricing and supply actions.
Sign In
Buy DBD